3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study.
Cheung
N K
NK
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center New York, NY 10021.
Kushner
B H
BH
Yeh
S J
SJ
Larson
S M
SM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D007223:Infant; D007262:Infusions, Intravenous; D008297:Male; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D012074:Remission Induction; D012189:Retrospective Studies; D016019:Survival Analysis
D000911:Antibodies, Monoclonal; D005732:Gangliosides; D007074:Immunoglobulin G; C019403:ganglioside, GD2